• Je něco špatně v tomto záznamu ?

Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism

H. Pilna, V. Hajkova, J. Knitlova, J. Liskova, J. Elsterova, Z. Melkova

. 2021 ; 13 (10) : . [pub] 20211003

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012116

Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encodes various factors interfering with host immune responses at multiple levels. In atopic skin, the production of type I interferon is compromised, while VACV specifically inhibits the phosphorylation of the Interferon Regulatory Factor 3 (IRF-3) and expression of interferons. To overcome this block, we generated a recombinant VACV-expressing murine IRF-3 (WR-IRF3) and characterized its effects on virus growth, cytokine expression and apoptosis in tissue cultures and in spontaneously atopic Nc/Nga and control Balb/c mice. Further, we explored the induction of protective immune responses against a lethal dose of wild-type WR, the surrogate of smallpox. We demonstrate that the overexpression of IRF-3 by WR-IRF3 increases the expression of type I interferon, modulates the expression of several cytokines and induces superior protective immune responses against a lethal poxvirus challenge in both Nc/Nga and Balb/c mice. Additionally, the results may be informative for design of other virus-based vaccines or for therapy of different viral infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012116
003      
CZ-PrNML
005      
20220506130947.0
007      
ta
008      
220425s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/v13101986 $2 doi
035    __
$a (PubMed)34696416
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pilna, Hana $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic $u BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Průmyslová 595, 252 50 Vestec, Czech Republic
245    10
$a Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism / $c H. Pilna, V. Hajkova, J. Knitlova, J. Liskova, J. Elsterova, Z. Melkova
520    9_
$a Vaccinia virus (VACV) is an enveloped DNA virus from the Orthopoxvirus family, various strains of which were used in the successful eradication campaign against smallpox. Both original and newer VACV-based replicating vaccines reveal a risk of serious complications in atopic individuals. VACV encodes various factors interfering with host immune responses at multiple levels. In atopic skin, the production of type I interferon is compromised, while VACV specifically inhibits the phosphorylation of the Interferon Regulatory Factor 3 (IRF-3) and expression of interferons. To overcome this block, we generated a recombinant VACV-expressing murine IRF-3 (WR-IRF3) and characterized its effects on virus growth, cytokine expression and apoptosis in tissue cultures and in spontaneously atopic Nc/Nga and control Balb/c mice. Further, we explored the induction of protective immune responses against a lethal dose of wild-type WR, the surrogate of smallpox. We demonstrate that the overexpression of IRF-3 by WR-IRF3 increases the expression of type I interferon, modulates the expression of several cytokines and induces superior protective immune responses against a lethal poxvirus challenge in both Nc/Nga and Balb/c mice. Additionally, the results may be informative for design of other virus-based vaccines or for therapy of different viral infections.
650    _2
$a zvířata $7 D000818
650    _2
$a exprese genu $x genetika $7 D015870
650    _2
$a regulace exprese virových genů $x genetika $7 D015967
650    _2
$a imunita $x imunologie $7 D007109
650    _2
$a interferonový regulační faktor 3 $x genetika $x imunologie $7 D050838
650    _2
$a interferon typ I $x metabolismus $7 D007370
650    _2
$a interleukin-1beta $x imunologie $7 D053583
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a Poxviridae $x patogenita $7 D011212
650    _2
$a infekce vyvolané poxviry $x imunologie $x prevence a kontrola $7 D011213
650    _2
$a kůže $x imunologie $7 D012867
650    _2
$a vakcínie $x virologie $7 D014615
650    _2
$a virus vakcinie $x genetika $7 D014616
650    _2
$a virové vakcíny $x imunologie $7 D014765
650    _2
$a replikace viru $x imunologie $7 D014779
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hajkova, Vera $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic $u BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Průmyslová 595, 252 50 Vestec, Czech Republic
700    1_
$a Knitlova, Jarmila $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic $1 https://orcid.org/0000000346074497
700    1_
$a Liskova, Jana $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic
700    1_
$a Elsterova, Jana $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic $1 https://orcid.org/0000000159213092
700    1_
$a Melkova, Zora $u Department of Immunology and Microbiology, First Faculty of Medicine, Charles University, Studnickova 7, 128 00 Prague 2, Czech Republic $u BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec, Průmyslová 595, 252 50 Vestec, Czech Republic $1 https://orcid.org/0000000297092110 $7 jo2002103068
773    0_
$w MED00177099 $t Viruses $x 1999-4915 $g Roč. 13, č. 10 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34696416 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130939 $b ABA008
999    __
$a ok $b bmc $g 1789628 $s 1163317
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 13 $c 10 $e 20211003 $i 1999-4915 $m Viruses $n Viruses $x MED00177099
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace